Interpace Biosciences Inc (IDXG)
1.468
+0.02
(+1.21%)
USD |
OTCM |
Apr 23, 16:00
Interpace Biosciences Price: 1.468 for April 23, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 1.522 | 1.535 | 1.45 | 1.468 | 4751.00 |
| Apr 22, 2024 | 1.43 | 1.45 | 1.429 | 1.45 | 860.00 |
| Apr 19, 2024 | 1.45 | 1.45 | 1.42 | 1.45 | 6513.00 |
| Apr 18, 2024 | 1.47 | 1.47 | 1.47 | 1.47 | 0.000 |
| Apr 17, 2024 | 1.47 | 1.47 | 1.47 | 1.47 | 0.000 |
| Apr 16, 2024 | 1.37 | 1.52 | 1.37 | 1.47 | 9335.00 |
| Apr 15, 2024 | 1.445 | 1.47 | 1.44 | 1.47 | 1421.00 |
| Apr 12, 2024 | 1.457 | 1.457 | 1.385 | 1.385 | 1585.00 |
| Apr 11, 2024 | 1.46 | 1.46 | 1.315 | 1.35 | 7944.00 |
| Apr 10, 2024 | 1.37 | 1.55 | 1.37 | 1.48 | 11430.00 |
| Apr 09, 2024 | 1.45 | 1.49 | 1.36 | 1.49 | 4301.00 |
| Apr 08, 2024 | 1.38 | 1.45 | 1.38 | 1.45 | 1276.00 |
| Apr 05, 2024 | 1.50 | 2.60 | 1.45 | 1.45 | 39210.00 |
| Apr 04, 2024 | 1.40 | 1.52 | 1.40 | 1.52 | 2996.00 |
| Apr 03, 2024 | 1.50 | 1.512 | 1.50 | 1.50 | 9203.00 |
| Apr 02, 2024 | 1.46 | 1.52 | 1.40 | 1.50 | 3566.00 |
| Apr 01, 2024 | 1.35 | 1.395 | 1.35 | 1.375 | 965.00 |
| Mar 28, 2024 | 1.53 | 1.53 | 1.43 | 1.50 | 637.00 |
| Mar 27, 2024 | 1.555 | 1.555 | 1.555 | 1.555 | 107.00 |
| Mar 26, 2024 | 1.629 | 1.64 | 1.60 | 1.60 | 3114.00 |
| Mar 25, 2024 | 1.62 | 1.62 | 1.62 | 1.62 | 3451.00 |
| Mar 22, 2024 | 1.52 | 1.62 | 1.52 | 1.62 | 825.00 |
| Mar 21, 2024 | 1.618 | 1.65 | 1.60 | 1.60 | 10134.00 |
| Mar 20, 2024 | 1.64 | 1.645 | 1.64 | 1.64 | 635.00 |
| Mar 19, 2024 | 1.50 | 1.50 | 1.50 | 1.50 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.66
Minimum
Dec 27 2022
10.55
Maximum
Feb 21 2020
4.527
Average
4.30
Median
Jan 25 2021
Price Benchmarks
| Fonar Corp | 16.09 |
| XWELL Inc | 1.42 |
| ProPhase Labs Inc | 5.20 |
| Applied DNA Sciences Inc | 0.287 |
| Veracyte Inc | 19.81 |
Price Related Metrics
| PS Ratio | 0.1607 |
| Earnings Yield | -3.41% |
| Market Cap | 6.422M |
| Operating PE Ratio | 2.136 |
| Normalized PE Ratio | 25.36 |